EM2107D "Bankrupt America or Short-Change the Patient? An Ethical Decision-Making Framework For Selecting the “Right” Medication" (IM GR-071621)
Medication costs in the United States have become increasingly burdensome for patients, providers and society over the past several years. This presentation seeks to provide a framework for medical providers and administrators to consider drug cost as part of an ethical decision-making process for medication selection. Basic ethical principles as well as underlying frameworks for “fair” distribution of resources will be discussed, acknowledging the values we hold as medical providers. Issues unique to the specialties of HIV medicine and infectious disease are highlighted; however, the framework is widely applicable to all prescribers of medications.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Analyze the implications of rising medication costs in the United States
- Evaluate the differences between “science” and “ethics” and how each are used in combination to make medical decisions
- Understand the terms of “quality-adjusted life years,” and “incremental cost-benefit analysis” as methods for measuring value of care
- Construct a internally-consistent ethical decision-making model for use in healthcare resource prioritization decisions
Ellen Kitchell, M.D.
Associate Professor, Department of Internal Medicine
Division of Infectious Diseases & Geographic Medicine
Associate Medical Director, HIV Clinical Services at Parkland Hospital
Associate Fellowship Director, HIV Fellowship
- 1.00 AMA
- 1.00 Ethics